Swedbank AB reduced its holdings in shares of Albemarle Co. (NYSE:ALB – Free Report) by 31.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 52,680 shares of the specialty chemicals company’s stock after selling 24,698 shares during the quarter. Swedbank AB’s holdings in Albemarle were worth $4,989,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in ALB. First Community Trust NA acquired a new position in Albemarle in the second quarter valued at approximately $25,000. CVA Family Office LLC boosted its holdings in shares of Albemarle by 610.0% in the 2nd quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 244 shares in the last quarter. Eastern Bank purchased a new position in shares of Albemarle in the 3rd quarter valued at $31,000. Cromwell Holdings LLC raised its stake in Albemarle by 61.9% during the 3rd quarter. Cromwell Holdings LLC now owns 387 shares of the specialty chemicals company’s stock worth $37,000 after acquiring an additional 148 shares in the last quarter. Finally, Cornerstone Advisors LLC lifted its position in Albemarle by 100.0% in the third quarter. Cornerstone Advisors LLC now owns 400 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 92.87% of the company’s stock.
Albemarle Stock Performance
NYSE ALB opened at $107.95 on Thursday. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43. The business’s 50 day moving average is $98.58 and its two-hundred day moving average is $98.69. The stock has a market capitalization of $12.69 billion, a price-to-earnings ratio of -6.44 and a beta of 1.55. Albemarle Co. has a 12-month low of $71.97 and a 12-month high of $153.54.
Albemarle Announces Dividend
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on the company. Robert W. Baird dropped their price objective on Albemarle from $85.00 to $79.00 and set a “neutral” rating on the stock in a report on Friday, October 25th. Mizuho cut their price target on Albemarle from $128.00 to $103.00 in a research report on Wednesday, July 31st. Piper Sandler decreased their price objective on Albemarle from $95.00 to $90.00 and set an “underweight” rating for the company in a report on Thursday, August 8th. Wells Fargo & Company lifted their target price on shares of Albemarle from $100.00 to $110.00 and gave the company an “equal weight” rating in a report on Tuesday, October 8th. Finally, Oppenheimer reduced their price target on shares of Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, fifteen have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Albemarle has a consensus rating of “Hold” and an average target price of $114.47.
Check Out Our Latest Report on Albemarle
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also
- Five stocks we like better than Albemarle
- 5 Top Rated Dividend Stocks to Consider
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 REITs to Buy and Hold for the Long Term
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.